CDK4/6 Inhibitor Resistant Breast Cancer Models
Leverage our extensive panel of CDK4/6 inhibitor resistant breast cancer models, including:
- In vitro induced Palbociclib resistant MCF-7 cell line
- In vivo induced Palbociclib resistant MCF-7 model
- In vivo induced Abemaciclib resistant MCF-7 model
- In vivo induced Ribociclib resistant MCF-7 model
View additional drug-resistant models in our platform
WuXi AppTec CDK4_6 inhibitor resistant models-Newsletter
Related Content
Ubiquitin-specific protease 7 (USP7) is a deubiquitinating enzyme that cleaves ubiquitin from a range of substrates, shielding them from degradation...
VIEW RESOURCEGPCRs: Function, Structure, and Classifications G protein-coupled receptors (GPCRs) are a prevalent class of transmembrane proteins in animal cells, representing...
VIEW RESOURCE